Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000655265 | SCV000777195 | benign | Adams-Oliver syndrome 5 | 2022-08-15 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV001281020 | SCV001468431 | uncertain significance | Aortic valve disease 1; Adams-Oliver syndrome 5 | 2021-03-30 | criteria provided, single submitter | clinical testing | NOTCH1 NM_017617.4 esxon 7 p.Ser417Leu (c.1250C>T): This variant has not been reported in the literature but is present in 0.008% (9/106554) of European alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/9-139412594-G-A). This variant is present in ClinVar (Variation ID:544189). Evolutionary conservation suggests that this variant may not impact the protein, but computational predicitve tools predict a deleterious effect. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Gene |
RCV001766427 | SCV001998677 | uncertain significance | not provided | 2020-01-10 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID# 544189; Landrum et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect |
Genome- |
RCV000655265 | SCV002553957 | uncertain significance | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270943 | SCV002553958 | uncertain significance | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002406493 | SCV002669064 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2022-05-30 | criteria provided, single submitter | clinical testing | The p.S417L variant (also known as c.1250C>T), located in coding exon 7 of the NOTCH1 gene, results from a C to T substitution at nucleotide position 1250. The serine at codon 417 is replaced by leucine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |